Low-density lipoprotein-lowering strategies: target versus maximalist versus population percentile
Current Opinion in Cardiology, 06/26/2012
Sniderman AD et al. – This analysis indicates that the LDL–lowering regimen should be tailored to the individual using a population percentile strategy to ensure the greatest number of patients receive the greatest overall benefit. With this approach, apoB is the best marker of the adequacy of LDL–lowering therapy.